Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Amateur's Manual for Venture Strategies for Tenderfoots - 2Surging measles cases are 'fire alarm' warning that other diseases could be next
- 3Instructions to Perceive and Grasp the Early Side effects of Cellular breakdown in the lungs
- 4What's going around right now? COVID, flu, stomach bug on the rise
- 5Vacuum Cleaners That Are Not difficult To Use For Home
- Vote in favor of Your #1 sort of pie
- Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- Outside Lovers' Decision: Favored Climbing Rucksacks
- The most effective method to Offset Album Rates with Liquidity Needs
- Unwinding the Starting points of America: An Excursion Through History
- Investigating the World's Chief Authentic Urban communities to Visit
- US FDA unveils new pathway to approve personalized therapies
- Viruses aren’t all bad: In the ocean, some help fuel the food web – a new study shows how
- Instructions to Keep an Inspirational perspective After Cellular breakdown in the lungs Treatment
